Clinical trial / 2013
Antioxidant treatments showed no significant effect on hearing measures in patients with presbyacusis over six months.
One hundred and twenty individuals with presbyacusis were randomized into four groups to receive ginkgo biloba dry extract, alpha-lipoic acid plus vitamin C, papaverine chlorhydrate plus vitamin E, or placebo for six months. Participants were evaluated at recruitment and after six months using pure tone audiometry, speech recognition threshold, and percentage index of speech recognition. The various treatments had no effect on any evaluated measures of hearing, either between groups or over time, with no statistically significant changes observed in hearing thresholds.
- Study type
- Prospective, placebo-controlled, double-blind, randomized trial
- Who was studied
- 120 individuals with presbyacusis
- What was measured
- Hearing threshold evaluated via pure tone audiometry, speech recognition threshold, and percentage index of speech recognition
THE PAPER
Evaluation of antioxidant treatment in presbyacusis: prospective, placebo-controlled, double-blind, randomised trial.
Polanski JF, Cruz OL. J Laryngol Otol, 2013.
This note is written from the study's published abstract. It summarizes what the authors reported; it is not medical advice and does not replace reading the full paper.